Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06307353
Other study ID # Soh_Med_23_12_05MS
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 1, 2024
Est. completion date March 1, 2025

Study information

Verified date March 2024
Source Sohag University
Contact Georgina F Zaghloul, resident
Phone 01210041433
Email georgina_fector_post_@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

family planning is avital primary Health care intervention that saves lives of mothers and infants empowers women and support their choices regarding their health public life and additional education .In addition family planning is considered as a short term intervention to limit population growth and manage overpopulation problems.Globally the contraception prevalance rate an indicator for family planning programs continue to face challenges in developing countries.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 385
Est. completion date March 1, 2025
Est. primary completion date October 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 49 Years
Eligibility Inclusion Criteria: - currently married woman in the child bearing period (15_49) years old attending El_Balyana urban medical Center Exclusion Criteria: women who are divorced or widowed or beyond age of fertility will be excluded -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
trends of contraception methods
family planning practice will include number of women current use of family planning methods and its type planning fot ffuture pregnancy suggested duration before next pregnancy.women'ssatisfaction with family planning services atElBalyana urban Medical Center accessibility of the site suitability of waiting time

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

References & Publications (4)

Harris ML, Coombe J, Forder PM, Lucke JC, Bateson D, Loxton D. Young Women's Complex Patterns of Contraceptive Use: Findings from an Australian Cohort Study. Perspect Sex Reprod Health. 2020 Sep;52(3):181-190. doi: 10.1363/psrh.12158. — View Citation

Mohamed NA, Abdel-Razik MS, Salem MR. Adjustment of family planning service statistics reports to support decision-making at central and governorate level, Egypt. J Egypt Public Health Assoc. 2022 Jan 20;97(1):4. doi: 10.1186/s42506-021-00098-7. — View Citation

Ntoimo L. Contraception in Africa: Is the global 2030 milestone attainable? Afr J Reprod Health. 2021 Jun;25(3):9-13. doi: 10.29063/ajrh2021/v25i3.1. No abstract available. — View Citation

Pimentel J, Ansari U, Omer K, Gidado Y, Baba MC, Andersson N, Cockcroft A. Factors associated with short birth interval in low- and middle-income countries: a systematic review. BMC Pregnancy Childbirth. 2020 Mar 12;20(1):156. doi: 10.1186/s12884-020-2852-z. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary number of married women in child bearing period attending the El_Balyana Medical Center using contraception methods . 1 year
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A